ABBVIE INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.5 USD | +0.57% |
|
+5.21% | +9.47% |
| 12:00pm | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
| Jun. 06 | AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 169.54 | 182.10 | 182.10 |
| Spread/Res. | -0.01% | -6.91% | -6.91% |
| Spread/Supp. | +5.69% | +11.75% | +8.63% |
| Support | 160.40 | 151.69 | 156.06 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
